Breaking News

Close

Gilead Sciences Inc (GILD)

	Symbol	Exchange	Currency
	GILD	NASDAQ	USD	Real-time
	GILD	Mexico	MXN	Delayed
	GGILD	Milan	EUR	Real-time
	GILD	Xetra	EUR	Delayed
	GILD	Frankfurt	EUR	Delayed
	GILD	TradeGate	EUR	Delayed
	GILD	Santiago	USD	Delayed
	GILDCL	Santiago	CLP	Delayed
	GILD	Buenos Aires	ARS	Delayed
	GILD	Vienna	EUR	Delayed

Add to/Remove from a Portfolio Add to Watchlist

87.83 +2.07 +2.41%

30/11 - Closed. Currency in USD ( Disclaimer )

Pre Market

87.68

-0.15

-0.17%

9:40:30 - Real-time Data

Volume: 12,431,890
Bid/Ask: 87.31 / 87.95
Day's Range: 85.01 - 88.15

Type: Equity

Market: United States

News
Analysis & Comment

GILD News

This page features the latest Gilead share news. Assess the latest information about the Gilead stock.

Gilead-Arcus Biosciences Partnered Lung Cancer Therapy Shows Continuous Positive Efficacy Measures

Gilead-Arcus Biosciences Partnered Lung Cancer Therapy Shows Continuous Positive Efficacy Measures By Benzinga - Nov 28, 2022

Benzinga - Gilead Sciences Inc (NASDAQ: NASDAQ:GILD) and Arcus Biosciences (NASDAQ: RCUS) announced an update from the fourth interim analysis of Phase 2 ARC-7 study in patients with first-line...

Gilead-Arcus Biosciences Partnered Lung Cancer Therapy Shows Continuous Positive Efficacy Measures

Gilead-Arcus Biosciences Partnered Lung Cancer Therapy Shows Continuous Positive Efficacy Measures

By Benzinga - Nov 28, 2022

Gilead Sciences Inc (NASDAQ: GILD) and Arcus Biosciences (NASDAQ: RCUS) announced an update from the fourth interim analysis of Phase 2 ARC-7 study in patients with first-line metastatic non-small...

Don't Use These 5 Non-Cost Effective COVID Treatments Including Antivirals From Merck and Gilead, Britain's NICE Says

Don't Use These 5 Non-Cost Effective COVID Treatments Including Antivirals From Merck and Gilead, Britain's NICE Says

By Benzinga - Nov 16, 2022

National Institute for Health and Care Excellence (NICE) has recommended stopping using five COVID-19 treatments, including Merck & Co Inc's (NYSE: MRK) antiviral pill for high-risk patients, citing...

US close: Dow soars 1,200 points after cooler inflation reading

US close: Dow soars 1,200 points after cooler inflation reading By Sharecast - Nov 11, 2022

Sharecast - At the close, the Dow Jones Industrial Average was up 3.7% at 33,715.37, as the S&P 500 added 5.54% to 3,956.37 and the Nasdaq Composite was 7.35% firmer at 11,114.15. The Dow closed...

Gilead Sciences PT Raised to $100 at Argus

Gilead Sciences PT receives Investment Bank Analyst Rating Update By Investing.com - Nov 09, 2022

Gilead Sciences PT Raised to $90 at Cowen

Gilead Sciences PT receives Investment Bank Analyst Rating Update By Investing.com - Nov 08, 2022

Gilead Sciences PT Raised to $88 at Mizuho Securities

Gilead Sciences PT receives Investment Bank Analyst Rating Update By Investing.com - Nov 08, 2022

US Supreme Court Throws Out Bristol Myers Appeal On Cancer-Drug Related Patent With Gilead

US Supreme Court Throws Out Bristol Myers Appeal On Cancer-Drug Related Patent With Gilead

By Benzinga - Nov 07, 2022

The U.S. Supreme Court turned away an appeal made by rebuffed efforts made by Bristol Myers Squibb Co's (NYSE: BMY) Juno Therapeutics Inc to reinstate a $1.2 billion award it won in its patent fight...

Gilead, Kite in process of pausing Twitter advertising

Gilead, Kite in process of pausing Twitter advertising

By FXEmpire - Nov 07, 2022

(Reuters) – Gilead Sciences Inc said on Monday the company and its unit Kite were in the “process of pausing advertising” on Twitter, after Elon Musk completed his takeover of the social media...

U.S. Supreme Court rejects Bristol Myers cancer-drug patent fight with Gilead

U.S. Supreme Court rejects Bristol Myers cancer-drug patent fight with Gilead

By FXEmpire - Nov 07, 2022

By Blake Brittain WASHINGTON (Reuters) -The U.S. Supreme Court on Monday rebuffed a bid by Bristol Myers Squibb Co’s Juno Therapeutics Inc to reinstate a $1.2 billion award it won in its patent fight...

1 2 3 4 5 6 7 8 9 10

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:

Enrich the conversation
Stay focused and on track. Only post material that’s relevant to the topic being discussed.
Be respectful. Even negative opinions can be framed positively and diplomatically.
Use standard writing style. Include punctuation and upper and lower cases.
NOTE: Spam and/or promotional messages and links within a comment will be removed
Avoid profanity, slander or personal attacks directed at an author or another user.
Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

I have read and understood Investing.com UK's comment guidelines and agree to the terms described.

GILD Comments

Write your thoughts about Gilead Sciences Inc

Are you sure you want to delete this chart?

Post also to:

Replace the attached chart with a new chart ?

1000

Comment Guidelines

Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.

Please wait a minute before you try to comment again.

Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.

Oc Masai Apr 27, 2021 7:54

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Good job GILD. bullish move forward

0 0

Ashraf Elgendy Mar 07, 2021 13:03

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Kite, a unit of Gilead Sciences (GILD),has announced that theFDA has granted approval for its T cell immunotherapy Yescarta (axicabtagene ciloleucel) for a certain category of adults...

2 1

RM RM Mar 01, 2021 21:53

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Up Again

1 0

Ken Laing Oct 23, 2020 18:43

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Time to load up before the big rise coming next week

3 3

Iggy Maldon Jul 30, 2020 20:22

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Classic pump n’ dump. What a shambles

5 1

RM RM May 28, 2020 22:24

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Will reach above 95

10 5

Chili Daug May 28, 2020 22:24

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

when? hahah

0 0

SAGAR AGARWAL May 15, 2020 14:52

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Good time to accumulate.

4 1

Khizer Malik May 14, 2020 11:04

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Gilead will be supplying remdesivir to 127 countries starting next week! Also backed by big government organisations including donald trump. Good investmenr

8 2

Willy Chin Apr 23, 2020 18:14

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

High chance to be trading above 90, good long stock

9 4

Viktor Veselý Apr 12, 2020 7:48

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

By Deena Beasley(Reuters) - More than two-thirds of severely ill COVID-19 patients saw their condition improve after treatment with remdesivir, an experimental drug being developed by Gilead Sciences Inc., according to new data based on patient observation.The analysis, published on Friday by the New England Journal of Medicine, does not detail what other treatments the 61 hospitalized patients were given and data on eight of them were not included -- in one case because of a dosing error.

4 3

<div id="comment">
				<div class="comment js-comment" data-comment-id="{commentID}" id="comment-{commentID}" data-user-id="204313794">
    <div class="mainComment js-content">
       <div class="commentInnerWrapper">
        <a href="{userLink}" class="js-user-link"><img src="{userImage}" width="33" height="33" alt="{usernameAlt}" class="img" onerror="this.src='https://i-invdn-com.investing.com/defaultUserMaleTmp.png';"></a><div class="commentBody">
                					<span class="commentUsername">
                    	<a href="{userLink}" class="js-user-link js-user-name">{username}</a>
					</span>
                                <span class="js-date" comment-date="{dateFormat}" comment-date-formatted="{dateFormatted}" title="{dateTitle}">Just Now</span>
                <div class="commentDropDown js-commentDropDownWrapper " data-user-id="204313794" data-cid="{commentID}">
	<a href="javascript:void(0);" class="threeDotsIconSmall js-thinDropdownArrow"></a>
	<div class="tooltipPopup commentActionsPop noHeader js-commentDropDownOptions displayNone">
		<div class="addRow js-option share">
			<a href="javascript:void(0);" class="js-commentSharePopup" data-cid="{commentID}" data-curl="{commentLink}"><span class="smallShareIcon middle"></span>Share</a>
		</div>

<div class="js-option addRow follow">
            <div class="js-follow-post-button" data-reg_ep="follow comment">
                <span class="alertfollowIcon middle"></span>Follow this post            </div>
            <div class="js-unfollow-post-button displayNoneImp">
                <span class="alertUnfollowIcon middle"></span>Unfollow this post            </div>
        </div>

<div class="addRow js-option save"  data-reg_ep="save comment">
		<a href="javascript:void(0);" class="js-save-item-btn" data-item-type="comments" data-item-id="{commentID}">
			<i class="saveItemBigIcon middle"></i>
			Save		</a>
	</div>
	<div class="addRow saveItemsConfirmation noHover displayNone js-saveItemResult">
		
<div class="content js-saveItemSuccess displayNone">
	<span class="mediumGreenSuccessIcon"></span><span>Saved. See <a href="/members-admin/saved-items" target="_blank">Saved Items</a>.</span>
	<a href="javascript:void(0);" class="bugCloseIcon js-close"></a>
</div>
<div class="content js-saveItemAlreadySaved saveItemAlreadySaved displayNoneImp">
	<span>This comment has already been saved in your <a href="/members-admin/saved-items" target="_blank">Saved Items</a></span>
	<a href="javascript:void(0);" class="bugCloseIcon js-close"></a>
</div>
	</div>

<div class="addRow js-option blockUser js-block-option" data-comment-id="{commentID}"  data-user-id="204313794" data-reg_ep="block user comments">
			<a href="javascript:void(0);">
				<span class="blockIcon middle"></span>Block User			</a>
		</div>
				<div class="addRow shareButtons js-sharePopup displayNone">
			<div class="js-shareComment"><span class="js-shareCommentSpan"></span></div>
		</div>
	</div>
</div>
                 <div class="commentAuthor js-comment-by-author"><span class="commentAuthorIcon"></span>Author's response</div>             </div>
		<div id="commentText-{commentID}" class="js-text-wrapper commentText withImage">
							<div id="commentBigChart{commentID}" class="commentBigChart js-comment-chart" onclick="openViewChartPopup('{commentID}')">
					<img src="https://d51-invdn-com.investing.com/comments_images/{commentImage}" alt="{commentAlt}">
					<i class="newMagnifyChartIcon"></i>
				</div>
						<span class="js-text">{commentContent}</span>
			<div class="clear"></div>
							<div class="commentButtons js-not-master-user">
					<a href="javascript:void(0)" class="reply js-reply-btn" data-real-parent-id="{commentID}" data-to-user-name="{username}" data-to-user-id="204313794">Reply</a>
					<div class="inlineblock likeDislikeBox js-like-dislike-box" data-item-id="{commentID}">
	<input class="js-like-checkbox" type="checkbox" name="option" value="Yes" id="like_{commentID}">
	<label for="like_{commentID}" class="like" title="I agree"></label>
	<span class="numOfLikes js-like-count lighterGrayFont">0</span>
	<input class="js-dislike-checkbox" type="checkbox" name="option" value="No" id="dislike_{commentID}">
	<label for="dislike_{commentID}" class="dislike" title="I disagree"></label>
	<span class="numOfDislikes js-dislike-count lighterGrayFont">0</span>
</div>

<div class="reportComment js-flag float_lang_base_2">
                            <a href="javascript:void(0);" id="commentFlag_{commentID}">
                                <span class="reportCommentIcon middle"></span><span class="inlineblock middle">Report</span>
                            </a>
                        </div>
                    				</div>
					</div>
	   </div>
	</div>
	</div>			</div>
			<div id="reply">
				
    <div class="commentReply js-comment js-comment-reply" data-comment-id="{commentID}" id="comment-{commentID}" data-user-id="200889478">
		<div class="commentInnerWrapper"><a href="{userLink}" class="js-user-link"><img src="{userImage}" width="33" height="33" alt="{usernameAlt}" class="img" onerror="this.src='https://i-invdn-com.investing.com/defaultUserMaleTmp.png';"></a><div class="commentBody js-content">
            				<span class="commentUsername">
					<a href="{userLink}" class="commentUsername js-user-link js-user-name" onMouseOver="">{username}</a>
				</span>
                        <span class="js-date" comment-date="{dateFormat}" comment-date-formatted="{dateFormatted}" title="{dateTitle}">Just Now</span>
			 <div class="commentAuthor js-comment-by-author"><span class="commentAuthorIcon"></span>Author's response</div> 			<div class="commentDropDown js-commentDropDownWrapper " data-user-id="200889478" data-cid="{commentID}">
	<a href="javascript:void(0);" class="threeDotsIconSmall js-thinDropdownArrow"></a>
	<div class="tooltipPopup commentActionsPop noHeader js-commentDropDownOptions displayNone">
		<div class="addRow js-option share">
			<a href="javascript:void(0);" class="js-commentSharePopup" data-cid="{commentID}" data-curl="{commentLink}"><span class="smallShareIcon middle"></span>Share</a>
		</div>

<div class="js-option addRow follow">
            <div class="js-follow-post-button" data-reg_ep="follow comment">
                <span class="alertfollowIcon middle"></span>Follow this post            </div>
            <div class="js-unfollow-post-button displayNoneImp">
                <span class="alertUnfollowIcon middle"></span>Unfollow this post            </div>
        </div>

<div class="addRow js-option save"  data-reg_ep="save comment">
		<a href="javascript:void(0);" class="js-save-item-btn" data-item-type="comments" data-item-id="{commentID}">
			<i class="saveItemBigIcon middle"></i>
			Save		</a>
	</div>
	<div class="addRow saveItemsConfirmation noHover displayNone js-saveItemResult">
		
<div class="content js-saveItemSuccess displayNone">
	<span class="mediumGreenSuccessIcon"></span><span>Saved. See <a href="/members-admin/saved-items" target="_blank">Saved Items</a>.</span>
	<a href="javascript:void(0);" class="bugCloseIcon js-close"></a>
</div>
<div class="content js-saveItemAlreadySaved saveItemAlreadySaved displayNoneImp">
	<span>This comment has already been saved in your <a href="/members-admin/saved-items" target="_blank">Saved Items</a></span>
	<a href="javascript:void(0);" class="bugCloseIcon js-close"></a>
</div>
	</div>

<div class="addRow js-option blockUser js-block-option" data-comment-id="{commentID}"  data-user-id="200889478" data-reg_ep="block user comments">
			<a href="javascript:void(0);">
				<span class="blockIcon middle"></span>Block User			</a>
		</div>
				<div class="addRow shareButtons js-sharePopup displayNone">
			<div class="js-shareComment"><span class="js-shareCommentSpan"></span></div>
		</div>
	</div>
</div>

</div>
		<div id="commentText-{commentID}" class="js-text-wrapper commentText withImage">
							<div id="commentBigChart{commentID}" class="replyBigChart displayNone js-comment-chart">
					<img src="https://d51-invdn-com.investing.com/comments_images/{commentImage}" alt="{commentAlt}">
					<i class="newMagnifyChartIcon"></i>
				</div>
				<span id="commentSmallChart{commentID}" class="commentSmallChart pointer js-comment-chart" onclick="openViewChartPopup('{commentID}')">
                    <img src="https://d51-invdn-com.investing.com/comments_images/{commentImageSmall}" width="116" height="52" alt="{commentAlt}">
                    <span class="chartMagnifyOverlay displayNone"></span>
                    <span class="searchGlassIcon chartMagnify displayNone"></span>
                </span>
						<span class="js-text">{commentContent}</span>
			<div class="clear"></div>
							<div class="commentButtons js-not-master-user">
					<a href="javascript:void(0)" class="reply js-reply-btn" data-real-parent-id="{commentID}" data-to-user-name="{username}" data-to-user-id="200889478">Reply</a>
					<div class="inlineblock likeDislikeBox js-like-dislike-box" data-item-id="{commentID}">
	<input class="js-like-checkbox" type="checkbox" name="option" value="Yes" id="like_{commentID}">
	<label for="like_{commentID}" class="like" title="I agree"></label>
	<span class="numOfLikes js-like-count lighterGrayFont">0</span>
	<input class="js-dislike-checkbox" type="checkbox" name="option" value="No" id="dislike_{commentID}">
	<label for="dislike_{commentID}" class="dislike" title="I disagree"></label>
	<span class="numOfDislikes js-dislike-count lighterGrayFont">0</span>
</div>

<div class="reportComment js-flag float_lang_base_2">
                            <a href="javascript:void(0);" id="commentFlag_{commentID}">
                                <span class="reportCommentIcon middle"></span><span class="inlineblock middle">Report</span>
                            </a>
                        </div>
                    				</div>
					</div>
		</div>
    </div>
			</div>
			<div id="show-more-comments">
				<a class="showMoreComments block">
					<span class="arial_12 showArrowafter">Show more comments (<span class="js-amount"></span>)</span>
				</a>
			</div>
			<div id="show-more-replies">
				<a class="showMoreReplies block">
					<span class="arial_12 showArrowafter">Show more replies (<span class="js-amount"></span>)</span>
				</a>
			</div>

Are you sure you want to delete this chart?

Replace the attached chart with a new chart ?

1000

Comment Guidelines

Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.

Please wait a minute before you try to comment again.

I feel that this comment is:

Spam

Offensive

Thank You!

Your report has been sent to our moderators for review

More Categories

1D1W1M6M1Y5YMax

	FTSE 100	7,582.80	+9.75	+0.13%
	DAX	14,458.15	61.11	0.42%
	Euro Stoxx 50	3,980.55	+15.83	+0.40%
	US 30	34,512.5	-77.3	-0.22%
	US 500	4,074.7	-5.4	-0.13%
	Nikkei 225	28,226.08	+257.09	+0.92%
	GBP Index	71.17	+0.12	+0.17%

	Brent Oil	87.62	+0.65	+0.75%
	Crude Oil WTI	81.18	+0.63	+0.78%
	Gold	1,792.45	+32.55	+1.85%
	Silver	22.312	+0.531	+2.44%
	Copper	3.7550	+0.0170	+0.45%
	London Cocoa	2,131.00	-8.00	-0.37%
	London Wheat	260.00	+0.00	+0.00%

	U.K. 10Y	3.1370	-0.0240	-0.76%
	U.K. 5Y	3.2425	-0.0215	-0.66%
	U.K. 2Y	3.2490	-0.0290	-0.88%
	Germany 10Y	1.8410	-0.1050	-5.40%
	U.S. 10Y	3.618	-0.083	-2.24%
	U.S. 5Y	3.7642	-0.0640	-1.67%
	U.S. 2Y	4.3346	-0.0370	-0.86%

	Lloyds Banking	46.93	+0.03	+0.05%
	Vodafone Group PLC	92.44	+0.60	+0.65%
	Barclays	161.56	+0.30	+0.19%
	BT Group	123.16	+1.70	+1.40%
	HSBC	505.30	-4.20	-0.82%
	BHP Group Ltd	2,565.00	-22.50	-0.87%
	Exxon Mobil	111.34	+0.80	+0.72%

Recent Quotes

	Name	Price	Chg.	Chg. %
	GILD	87.83	+2.07	+2.41%

	Name	Last	Chg. %	Vol.
	Glencore	556.20	-1.29%	10.25M
	HSBC	505.50	-0.82%	5.67M
	BP	490.67	-1.37%	914.92K
	Unilever	4,167.5	+0.57%	512.30K
	Rio Tinto PLC	5,564.0	-0.38%	418.14K
	AstraZeneca	11,172.0	+0.05%	195.88K
	Shell	2,400.0	-1.80%	135.26K

	Name	Last	Chg. %	Vol.
	Spar Nord Bank	105.20	+52.91%	2.21K
	SAF Holland	9.34	+39.43%	0.10K
	Parsley Box Group	6.60	+28.85%	9.32M
	Anemoi International	1.08	+18.42%	1.06M
	Tpximpact Holdings	47.00	+17.50%	19.78K
	PetroNeft	0.350	+16.67%	750.00K
	Deepmatter	0.040	+14.29%	43.13M

	Name	Last	Chg. %	Vol.
	CC Japan	0.05	-90.46%	15.27K
	H Lundbeck B	26.25	-84.89%	7.72K
	Dassault Aviation	149.40	-83.82%	0.72K
	BioGaia B	86.05	-83.31%	2.33K
	Dassault Systemes	36.31	-82.65%	63.42K
	Atlas Copco B	117.66	-68.86%	105.06K
	AMS	7.98	-61.28%	9.20K